MK

Mukesh Kumar Goud

Active Director Director DIN 10622817
DIN 10622817 First appointment May 2024 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Mukesh Kumar Goud

Data last updated:

Mukesh Kumar Goud is a Director at Livzon Pharmaceuticals Private Limited (since 2024). The company operates in Pharma.

DIN 10622817
Primary Designation Director
Industry Pharma
First Appointment 09 May 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director09 May 20242024Active

Board colleagues of Mukesh Kumar Goud

NameDINCompanyDesignation
Divyansh Goud10887798Livzon Pharmaceuticals Private LimitedAdditional Director

Directorship timeline

Open interactive timeline →
Livzon Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Mukesh Kumar Goud

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mukesh Kumar Goud

Mukesh Kumar Goud currently holds 1 directorship: Livzon Pharmaceuticals Private Limited (Director, since 09 May 2024).

Mukesh Kumar Goud was first appointed on 09 May 2024 as Director at Livzon Pharmaceuticals Private Limited.

The current boards of Mukesh Kumar Goud's companies include Divyansh Goud (Livzon Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available